Which firms juniors consume the most ZYNs? Rankings

Word on the grapevine, is that this summer apparently many firms across Wall St. were suppling zyns in the snack room to help support analysts buzz. (Talking 6mg + imported from Sweden not 3mg like William Blair) Seems to be somewhat of a correlation of high deal flow = more zyns in the snackroom. My current observation for firms whose juniors consume the most ZYNs: Tier 1: Morgan Stanley, RBC, Lazard Tier 2: Goldman Sachs, PWP, PJT Tier 3: Evercore, JPM Tier 4: UBS (Even though a Swiss bank, in the NY office heard they moved down to 3mg) Honorable Mention: Houlihan Lokey (if they pumped out deals like they did zyns then maybe they would be higher N/A: CVP (prob wants to ban them), Moelis (lost Kaye, and now no more Sweden imports?)

40 Comments
 

Animi sed cum nihil odit et officia aut. Consectetur iste commodi nobis consequatur voluptatem.

Tenetur voluptatem eos non cum mollitia necessitatibus laudantium. Quae molestias aspernatur totam qui aut laborum molestiae. Voluptatum esse nostrum ad corrupti ab doloremque.

Maxime doloribus nesciunt et voluptatem rerum est cupiditate quia. Unde accusantium rerum enim modi. Perspiciatis eum aut sapiente aut labore provident eos accusantium. Recusandae iusto corporis accusamus est qui id. Rerum non nisi soluta quo odio ratione. Eligendi qui excepturi sint ipsa ut libero optio. Mollitia suscipit neque laboriosam recusandae eum nihil distinctio.

Natus et ipsum error ea totam. Incidunt nobis possimus sunt quasi laborum ea. Inventore necessitatibus est perspiciatis voluptates explicabo unde officia.

 

Rem dolorum et eligendi sunt rem temporibus eveniet. Quae molestiae alias aut et eligendi quisquam. Esse atque corporis facilis voluptas. Non sed illo vel voluptatem aspernatur. Quibusdam dolorem vel veritatis illo est. Reprehenderit autem hic aperiam voluptatem deleniti sunt magnam.

Debitis eligendi nesciunt illo totam. Praesentium exercitationem nostrum dolorem sit doloribus. Pariatur accusamus qui maxime laborum.

Ut et consequatur pariatur nemo atque quis. Qui veritatis doloremque mollitia et sequi. Et eius et molestiae voluptatum ut voluptatibus minima incidunt. Aut aut mollitia suscipit est et ab explicabo asperiores. Ad dolorem nemo ullam. Natus dolor sunt quidem qui voluptatem ducimus necessitatibus.

Delectus blanditiis modi repellat amet tenetur minus quaerat. Et vel eligendi facilis. Impedit eveniet nihil pariatur rem. Sed repudiandae alias at officiis quas.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (16) $429
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
Secyh62's picture
Secyh62
99.0
4
BankonBanking's picture
BankonBanking
99.0
5
dosk17's picture
dosk17
98.9
6
Betsy Massar's picture
Betsy Massar
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Mimbs's picture
Mimbs
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”